#29: The Longevity Boom: How to Show Up As The Clinician Patients Actually Need

In 2020, longevity medicine was a niche experiment. In 2026, it's in the living room.

The patient sitting across from you has run their own Function Health labs, tracked their HRV for six months on Oura, consumed 40 hours of longevity podcasts, and passed their results through ChatGPT before booking the appointment. They may already have a protocol. They're not coming to you for more information — they're coming for a clinician who can help separate signal from noise.

That shift didn't happen by accident. The infrastructure of longevity medicine has been quietly reaching consumers for years, and the scale of it is now hard to ignore. Over 800 longevity clinics operate in the US. Fountain Life raised $108M. Serotonin Centers crossed 100 franchise locations. Gameday Men's Health has 400+ locations across the US and Canada. Weill Cornell launched a 12-month Longevity Medicine Program. Northwestern opened the Human Longevity Clinic. Mayo Clinic is building its own. UBS projects the market will reach $8 trillion by 2030.

When governments regulate and medical schools add curriculum, a field has arrived.

But the boom hasn't solved the fundamental problem — it's created a new one. Consumers can now access more longevity data, protocols, and tools than ever before. What they can't access is a clinician who knows what to do with all of it. That's you. And how you show up for that conversation will define your practice in the years ahead.

The longevity boom has a structural problem: most of it is being built at the extremes.

On one end, capital-intensive brick-and-mortar clinics spending millions on real estate and equipment before seeing their first patient. On the other, direct-to-consumer platforms with no physician oversight and no accountability when the protocol doesn't work. In between, concierge practices with loyal patient bases and no longevity expertise.

None of them is what the market actually needs.

The white space belongs to the independent clinician who owns their practice, serves a carefully selected patient panel, and builds something no franchise can replicate: a real clinical relationship, grounded in evidence, tracked with outcomes over time. These clinicians don't compete on price. They compete on results.

That position is still wide open. But it requires getting one thing right: how you engage the patient who already thinks they know what they need.

Three types of self-directed longevity patients are showing up with increasing frequency.

The Quantified Self. Arrives with six months of Oura ring data, a continuous glucose monitor report, and a direct-ordered epigenetic age test from TruDiagnostic or Elysium. Genuinely engaged. Usually has decent instincts. Needs synthesis more than correction.

The Podcast Patient. Found you via Huberman, Attia, or Rhonda Patrick. Has a supplement stack — probably NMN, creatine, magnesium glycinate, and something more exotic. May have started metformin through a telehealth service. Motivated but operating without a clinical framework. Needs structure.

The AI Protocol Patient. Ran their labs through ChatGPT, got a "personalized longevity protocol," and wants you to co-sign it. Buried in the output might be three things that are right, two that are irrelevant, and one that's actively contraindicated given their history. This one requires the most care.

All three patients share something: they came to you because they want a clinician in their corner, not just a prescription pad. The mistake is treating their self-research as a threat to your authority. It isn't. It's an opening.

The clinicians doing this well have developed a consistent intake posture.

Acknowledge the homework. Patients who've done research want to know it wasn't wasted. Start there: "You've clearly been thinking carefully about this — let's go through what you've found and build on it."

Reframe the goal. Your job isn't to validate or invalidate their protocol. It's to add the clinical layer they can't add themselves: longitudinal context, contraindication screening, outcome tracking, and the judgment that comes from having seen what works over years.

Establish the standard. Every intervention gets evaluated on the same criteria: evidence quality, appropriateness for their specific physiology, and fit within an integrated protocol. That framework — consistently applied — is your clinical authority.

The patients who stay and refer others are the ones who leave the first visit feeling their curiosity was met, not managed.

1. Send a pre-visit intake that honors their work. Ask them to share any labs from the last 12 months, wearable data summaries, current supplements with dosing, and any protocols they've started. This signals you take it seriously — and gives you 20 minutes of visit prep instead of 20 minutes of in-room catch-up.

2. Open with synthesis, not assessment. Start by summarizing what their data shows in your clinical interpretation: "What I see here is a picture of someone with strong cardiovascular markers but early signs of metabolic inflexibility — which actually changes how we'd prioritize the longevity stack." You're adding the clinical layer, not competing with theirs.

3. Run every intervention through a three-question filter. Evidence quality (what does the data actually show for this phenotype?), individual fit (any contraindications or history that changes the calculus?), protocol integration (does this fit coherently with everything else?). Walk through this out loud for one or two items in the first visit. It shows your work and builds trust faster than conclusions alone.

4. Build a shared outcomes dashboard. Agree on 3–5 biomarkers you'll track together over the next 6–12 months. This turns the relationship from episodic visits to a continuous clinical partnership — and gives you outcomes data that franchises, focused on acquisition, almost never collect.

5. Close with a ranked protocol, not a list. Patients who arrive with ten things they want to try need prioritization, not approval. Give them: "Here's what I'd start with, here's why, and here's what we're watching for." A ranked protocol is a clinical artifact. A list of supplements is just shopping.

Here's what the longevity gold rush is really a race to own: the patient relationship layer. Franchises are spending millions on real estate to capture it. Consumer platforms are spending millions on apps. Everyone is trying to build the interface between the patient's health data and a clinical relationship.

Most of them are building it without physicians at the center.

That's the gap Vibrant Practice was built for. We're now live with 70+ leading functional, integrative, and longevity clinics across the country — and what we've found is that the highest-leverage thing technology can do for a modern clinician isn't replace clinical judgment. It's make the patient journey legible: easier to navigate complex lab results, easier to create and deliver custom protocols, easier to keep patients engaged in the longer arc of their health rather than just the next appointment.

The consumer layer is coming regardless. Your patients are already using Function Health, TruDiagnostic, Oura. The question isn't whether they'll arrive with data — it's whether your practice has the infrastructure to receive it, synthesize it, and build on it over time.

Wearables integration is coming to Vibrant very soon — so the continuous data your patients are generating starts flowing directly into the clinical picture, not sitting siloed in a separate app. And white-labeled patient health reports are on the roadmap: your patients receive branded, clinician-authored summaries of where they are and where they're going — with your practice name at the top, not a generic platform.

The independent clinician who owns this layer owns the relationship. That's the position worth building.

Be a modern clinician with the help of Vibrant, the AI-powered EHR built specifically for personalized medicine.

The thymus is back — and it's a longevity biomarker: Two studies published in Nature this month analyzed thymic health in 25,000+ adults using AI-enhanced CT scans and found that people with high thymic health scores had 50% lower risk of death, 63% lower cardiovascular mortality, and 36% lower lung cancer risk over 12 years. The thymus — long considered irrelevant after childhood — turns out to be a major predictor of immune resilience and longevity in adults. One to add to the patient conversation, especially for those tracking biological age.

Longevity clinics: between promise and peril: A new PMC review published this month takes an unflinching look at the longevity clinic industry — calling out the gap between marketing claims and outcomes evidence, the regulatory grey zones, and the training deficits across the space. Worth reading as both a competitive brief and a reminder of what distinguishes evidence-grounded practice from longevity theater.

Perplexity just launched a consumer health AI — and your patients are already using it: Perplexity Health launched March 19 with connectors to Apple Health, wearables (Fitbit, Ultrahuman, Withings), and EHR data from 1.7 million care providers. It's not a diagnostic tool — Perplexity is explicit about that — but it's a health reasoning layer your patients now have in their pocket. Amazon, Microsoft Copilot Health, and ChatGPT Health are all racing for the same position. The consumer health AI race is now fully underway, and your patients are the prize. The clinicians who understand these tools will have better conversations with the patients using them.

The calendar is filling up. A few worth putting on your radar - and a chance to connect with the Vibrant community in person!

Apr 8–11 — HINT Summit · Nashville, TN The anchor conference for Direct Primary Care and membership medicine. If you're evaluating or scaling a membership model, this is where the operational knowledge lives. Vibrant will be there!

Apr 13 — Vibrant Community Webinar “All Things Peptides with Leonard Pastrana, nuAgeBio“ Virtual Event Join Sunita and Leonard Pastrana to discuss the latest changes in the peptide regulatory landscape and what it means for your practice.

Apr 10–12 — A4M Spring Congress · West Palm Beach, FL The A4M's flagship spring gathering for anti-aging and longevity medicine practitioners. Strong mix of clinical science and practice building. Vibrant (just Sunita) will be there!

May TBD — Vibrant Community Webinar “AI Skills for the Modern Clinician“ Virtual. Join Dr. G and Dr. Sunjya Schweig to walk through the new competencies for the AI-savvy clinician, along with tangible tips for using a variety of tools in your practice.

May 27–30 — IFM Annual International Conference · San Diego, CA The largest gathering of functional medicine clinicians in the world. This year's program reflects the field's rapid expansion into AI-assisted care and multi-omics diagnostics. Vibrant will be there!

Jun 9–11 — Longevity Docs Cannes 2026 · Cannes, France Awards and summit for longevity medicine's emerging leaders. A smaller, high-signal event for clinicians building practices at the frontier.

Nov 5-7 — Private Physicians Alliance Annual Meeting · St. Petersburg, FL The gathering for independent, cash-pay, and concierge physicians navigating practice independence. Practical and peer-driven. Vibrant will be there!

Nov 8-11 — American College of Lifestyle Medicine Conference · Orlando, FL Lifestyle medicine's main annual event — evidence-based approaches to behavior change, chronic disease, and healthspan. Growing overlap with the longevity medicine community. Vibrant will be there!

TBA — Longevity Clinics Roundtables · Buck Institute Clinical practice meets research infrastructure. One for the clinicians who want to be closer to where the science is actually being made.

Know of an event we should add to the list? Reply and let us know.

The longevity boom is real. So is the noise. The clinicians who will define what this field becomes aren't the ones with the biggest marketing budgets or the nicest facility buildouts. They're the ones building patient relationships deep enough to generate real outcomes data — and clinical reputations that no franchise can replicate.

If you're navigating the informed patient conversation and have found something that works, reply and share it. The best ideas in this newsletter come from clinicians doing the work.

Until next Thursday — keep building the practice you imagined when you started. We're building it with you.

-Sunita and Dr. G

The Modern Clinician is written for functional, integrative, and longevity-focused physicians who want to scale their impact and deliver cutting-edge care.

If you liked this one, share it with a colleague! We appreciate you spreading the word.

To learn more about the why behind this newsletter, start with our first post introducing The Modern Clinician.